News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
758,516 Results
Type
Article (46447)
Company Profile (270)
Press Release (711786)
Multimedia
Podcasts (110)
Webinars (22)
Section
Business (209692)
Career Advice (2132)
Deals (36295)
Drug Delivery (148)
Drug Development (83291)
Employer Resources (175)
FDA (17239)
Job Trends (15352)
News (355394)
Policy (33842)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2787)
Accelerated approval (56)
ADA (47)
Adcomms (32)
Allergies (197)
Alliances (51433)
ALS (233)
Alzheimer's disease (1881)
Antibody-drug conjugate (ADC) (529)
Approvals (17704)
Artificial intelligence (756)
ASCO (330)
Autoimmune disease (361)
Automation (65)
Bankruptcy (368)
Best Places to Work (11903)
BIO (68)
BIOSECURE Act (20)
Biosimilars (237)
Biotechnology (179)
Bladder cancer (206)
Brain cancer (77)
Breast cancer (816)
Cancer (6413)
Cardiovascular disease (554)
Career advice (1811)
Career pathing (47)
CAR-T (366)
CDC (59)
Celiac Disease (3)
Cell therapy (996)
Cervical cancer (57)
Clinical research (72768)
Collaboration (2284)
Commercialization (1)
Company closure (5)
Compensation (1508)
Complete response letters (88)
COVID-19 (2841)
CRISPR (122)
C-suite (1257)
Cystic fibrosis (159)
Data (8742)
Decentralized trials (3)
Denatured (34)
Depression (177)
Dermatology (97)
Diabetes (680)
Diagnostics (7212)
Digital health (66)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (373)
Drug pricing (216)
Drug shortages (32)
Duchenne muscular dystrophy (305)
Earnings (93338)
Editorial (70)
Employer branding (21)
Employer resources (157)
Events (123799)
Executive appointments (1152)
FDA (21320)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (35)
Funding (1916)
Gene editing (259)
Generative AI (64)
Gene therapy (781)
GLP-1 (1137)
Government (4923)
Grass and pollen (6)
Guidances (422)
Healthcare (19829)
Hematology (196)
HIV (93)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (113)
Immunology and inflammation (315)
Immuno-oncology (108)
Indications (221)
Infectious disease (3213)
Inflammatory bowel disease (226)
Inflation Reduction Act (15)
Influenza (145)
Intellectual property (319)
Interviews (333)
IPO (16871)
IRA (52)
Job creations (3733)
Job search strategy (1499)
JPM (60)
Kidney cancer (21)
Labor market (113)
Layoffs (587)
Leadership (44)
Legal (8157)
Liver cancer (105)
Longevity (36)
Lung cancer (845)
Lymphoma (484)
Machine learning (67)
Management (62)
Manufacturing (1180)
Marketing (4)
MASH (211)
Medical affairs (1)
Medical device (14618)
Medtech (14797)
Mergers & acquisitions (20741)
Metabolic disorders (1685)
mRNA (241)
Multiple sclerosis (206)
NASH (18)
Neurodegenerative disease (470)
Neuropsychiatric disorders (112)
Neuroscience (3565)
Neurotech (1)
NextGen: Class of 2026 (6810)
Non-profit (4680)
Now hiring (82)
Obesity (779)
Opinion (313)
Ovarian cancer (244)
Pain (272)
Pancreatic cancer (357)
Parkinson's disease (407)
Partnered (36)
Patents (642)
Patient recruitment (782)
Peanut (69)
People (61254)
Pharmaceutical (56)
Pharmacy benefit managers (35)
Phase 1 (22725)
Phase 2 (32048)
Phase 3 (23815)
Pipeline (9966)
Policy (344)
Postmarket research (2637)
Preclinical (9750)
Press Release (69)
Prostate cancer (337)
Psychedelics (59)
Radiopharmaceuticals (351)
Rare diseases (1220)
Real estate (6136)
Recruiting (72)
Regulatory (26678)
Reports (56)
Research institute (2566)
Resumes & cover letters (371)
Rett syndrome (46)
RNA editing (27)
RSV (91)
Schizophrenia (185)
Series A (329)
Series B (242)
Service/supplier (12)
Sickle cell disease (121)
Special edition (27)
Spinal muscular atrophy (169)
Sponsored (48)
Startups (3783)
State (2)
Stomach cancer (18)
Supply chain (136)
Tariffs (88)
The Weekly (73)
Vaccines (1188)
Venture capital (128)
Weight loss (502)
Women's health (139)
Worklife (21)
Date
Today (128)
Last 7 days (500)
Last 30 days (2483)
Last 365 days (30913)
2026 (16501)
2025 (30756)
2024 (35834)
2023 (40857)
2022 (52033)
2021 (56680)
2020 (55266)
2019 (48051)
2018 (36193)
2017 (33189)
2016 (32700)
2015 (38833)
2014 (32598)
2013 (27793)
2012 (29965)
2011 (30592)
2010 (28740)
Location
Africa (789)
Alabama (94)
Alaska (7)
Arizona (373)
Arkansas (15)
Asia (41840)
Australia (6862)
California (14134)
Canada (3986)
China (1526)
Colorado (607)
Connecticut (632)
Delaware (436)
Europe (92035)
Florida (2160)
Georgia (461)
Hawaii (3)
Idaho (67)
Illinois (1172)
India (102)
Indiana (638)
Iowa (26)
Japan (607)
Kansas (136)
Kentucky (53)
Louisiana (59)
Maine (76)
Maryland (1683)
Massachusetts (10216)
Michigan (377)
Minnesota (778)
Mississippi (7)
Missouri (161)
Montana (36)
Nebraska (30)
Nevada (152)
New Hampshire (87)
New Jersey (3691)
New Mexico (32)
New York (3737)
North Carolina (1802)
North Dakota (10)
Northern California (7140)
Ohio (427)
Oklahoma (25)
Oregon (44)
Pennsylvania (2801)
Puerto Rico (31)
Rhode Island (52)
South America (1165)
South Carolina (87)
South Dakota (2)
Southern California (5597)
Tennessee (232)
Texas (2274)
United States (50107)
Utah (419)
Vermont (2)
Virginia (352)
Washington D.C. (82)
Washington State (1152)
West Virginia (4)
Wisconsin (136)
Wyoming (2)
758,516 Results for "cardiovascular systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cardio Diagnostics Holdings, Inc. to Showcase Precision Cardiovascular Solutions at Four National Benefits Conferences in June 2026
May 27, 2026
·
5 min read
Press Releases
Novo Nordisk global observational study reveals 2 in 5 people with cardiovascular disease have cardiovascular inflammation, increasing their risk of heart attack and stroke
May 26, 2026
·
8 min read
NextGen
Corsera Eyes Two-Pronged Approach To Tackle Leading Cardiovascular Killer
Corsera Health’s Chief Operating Officer Rena Denoncourt and CFO Meredith Kaya speak with
BioSpace
about the biotech’s mission and vision for the next generation of cardiovascular care.
February 24, 2026
·
2 min read
·
Annalee Armstrong
Collaboration
Lilly Fronts $100M for CSL’s IL-6 Blocker to Bolster I&I, Cardiovascular Pipeline
CSL is advancing clazakizumab for the treatment of cardiovascular events in end-stage kidney disease and will retain rights over the asset in this indication. Lilly will explore other conditions.
February 18, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Starlight Cardiovascular Announces First Baby in the World Treated with Lifeline Stent System at Cincinnati Children’s Hospital
March 24, 2026
·
2 min read
Press Releases
Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study
June 16, 2026
·
8 min read
Press Releases
CardioPharma Reviews Applications to Explore Non-Cardiovascular Benefits of CVD Polypill
May 12, 2026
·
4 min read
Press Releases
Huxley Medical Expands SANSA Diagnostic Platform with Point-of-Care Enrollment and Additional Cardiovascular Risk Marker
June 10, 2026
·
3 min read
Press Releases
Reprieve Cardiovascular Announces Publication of FASTR Pilot Trial Results in JACC: Heart Failure
May 8, 2026
·
5 min read
Press Releases
Madrigal Presents Data Demonstrating Rezdiffra Reduced Markers of Cardiovascular and Liver-Related Risk in Patients with MASH
May 27, 2026
·
15 min read
1 of 75,852
Next
